Position in RPRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$73,312,309
+$1,622,344 QoQ
Shares Held
1,307,514
-12.5% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#47
of 635 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $324,055,173 across 66 Biotechnology names. RPRX ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
174,812 | $86,834,364 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
1,307,514 | $73,312,309 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,523 | $40,856,211 | |
| 4 | INCY |
Incyte Corp
|
312,130 | $35,383,056 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,646 | $28,190,254 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
65,240 | $12,218,147 | |
| 7 | INSM |
INSMED Inc
|
91,077 | $9,710,629 | |
| 8 | EXEL |
Exelixis, Inc.
|
170,171 | $9,259,004 |
All Filings in RPRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,312,309 | 1,307,514 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $71,689,965 | 1,494,475 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $68,171,353 | 1,764,269 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $53,579,699 | 1,518,699 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $61,884,695 | 1,717,588 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $54,080,217 | 1,737,238 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $47,681,811 | 1,869,142 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $56,758,395 | 2,006,306 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $48,279,962 | 1,830,867 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $56,397,028 | 1,856,998 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $47,239,991 | 1,681,737 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $49,635,883 | 1,828,883 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $46,947,111 | 1,527,232 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $57,246,804 | 1,588,865 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $59,047,976 | 1,494,129 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $62,822,192 | 1,563,519 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $54,645,693 | 1,299,850 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $6,848,348 | 175,779 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,192,485 | 180,489 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,966,110 | 109,743 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,274,313 | 104,277 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,697,218 | 107,685 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,081,926 | 81,557 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||